Acer Therapeutics (ACER) Misses Q2 EPS by 7c

Acer Therapeutics (NASDAQ: ACER) reported Q2 EPS of ($0.33), $0.07 worse than the analyst estimate of ($0.26).

For earnings history and earnings-related data on Acer Therapeutics (ACER) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Algorhythm Holdings (RIME) Tops Q2 EPS by 54c